To the Editor:Type 2 diabetes(T2DM)is a significant health issue in China,with the age-standardized prevalence rising 2.5-fold from 1990 to 9.96%in 2021.[1]Despite this rise,only 32.9%of patients received treatment,an...To the Editor:Type 2 diabetes(T2DM)is a significant health issue in China,with the age-standardized prevalence rising 2.5-fold from 1990 to 9.96%in 2021.[1]Despite this rise,only 32.9%of patients received treatment,and just 50.1%achieved controlled blood sugar.[1]The Chinese Diabetes Society(CDS)advocates for self-monitoring of blood glucose(SMBG)to help patients track levels and manage their condition.[2]While SMBG has been shown to lower HbA1c in type 1 diabetes and untreated type 2 diabetes(T2D),large-scale evidence for its effect in insulin-treated T2D is still limited.展开更多
文摘To the Editor:Type 2 diabetes(T2DM)is a significant health issue in China,with the age-standardized prevalence rising 2.5-fold from 1990 to 9.96%in 2021.[1]Despite this rise,only 32.9%of patients received treatment,and just 50.1%achieved controlled blood sugar.[1]The Chinese Diabetes Society(CDS)advocates for self-monitoring of blood glucose(SMBG)to help patients track levels and manage their condition.[2]While SMBG has been shown to lower HbA1c in type 1 diabetes and untreated type 2 diabetes(T2D),large-scale evidence for its effect in insulin-treated T2D is still limited.
